Evaluación farmacoeconómica del tratamiento de la depresión bipolar

Translated title of the contribution: Pharmacotherapy for bipolar depression: An economic assessment

Charles Bowden, Jodi Gonzalez

Research output: Contribution to journalReview articlepeer-review


Bipolar disorders I and II (BPD) is a common, severe and recurrent mood disorder associated with high rates of comorbidities, suicide, dysfunction and a high socio-economic burden. Although the management of BPD has traditionally focused on the acute treatment of mania, the chronic nature of BPD necessitates long-term maintenance treatment. Bipolar depression is the predominant mood state in BPD and causes greater disability and economic burden than mania. Maintenance pharmacotherapy can reduce rates of future episodes, and subsequently, the associated risks, functional disability and economic burden of bipolar illness. Copyrigth

Translated title of the contributionPharmacotherapy for bipolar depression: An economic assessment
Original languageSpanish
Pages (from-to)264-269
Number of pages6
Issue number3
StatePublished - Aug 1 2008


  • Bipolar depression
  • Bipolar disorder
  • Maintenance treatment
  • Pharmacoeconomics
  • Pharmacotherapy

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Pharmacotherapy for bipolar depression: An economic assessment'. Together they form a unique fingerprint.

Cite this